CENTRAL BLOOD PRESSURE MEASUREMENT AS A PREDICTOR OF CARDIOVASCULAR RISK IN SYSTEMIC ARTERIAL HYPERTENSION: A SYSTEMATIC REVIEW

Abstract

Introduction: Systemic Arterial Hypertension (SAH) is a chronic non-communicable disease significantly affecting cardiovascular outcomes. Central Blood Pressure Measurement (CBPM) is more effective than traditional methods in predicting these outcomes. OBJECTIVE: To evaluate CBPM’s predictive power on cardiovascular outcomes in hypertensive patients.Methodology: Searches were performed in PubMed, LILACS and Cochrane, without language or time limits. Two independent reviewers conducted selection and risk of bias assessment, with agreement evaluated by Kappa. Data were organized in Excel for descriptive analysis.Results: From 3,962 identified articles, 25 studies met inclusion criteria. Selection strictly followed predefined criteria.Conclusion: CBPM surpasses brachial measurement in estimating cardiovascular risk. Central systolic pressure has a stronger link with adverse cardiovascular events, reflecting hemodynamic load on target organs. CBPM-derived parameters correlate with subclinical lesions. Individual factors affect interpretation, underscoring the need for personalized assessment. CBPM also supports early risk stratification and therapy monitoring, indicating that reducing central pressure can decrease cardiovascular load and optimize hypertension management.